Detalles de la búsqueda
1.
BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial Cancer.
Int J Mol Sci
; 23(13)2022 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35806162
2.
Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis.
Int J Mol Sci
; 23(9)2022 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35563509
3.
Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis.
Int J Mol Sci
; 23(11)2022 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35682653
4.
NKX6-1 mediates cancer stem-like properties and regulates sonic hedgehog signaling in leiomyosarcoma.
J Biomed Sci
; 28(1): 32, 2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33906647
5.
TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target.
J Pathol
; 248(3): 363-376, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30883733
6.
E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness.
Cancer Sci
; 110(3): 1085-1095, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30582655
7.
[Research rules of famous veteran traditional Chinese medicine practitioners in treating infertility].
Zhongguo Zhong Yao Za Zhi
; 44(7): 1491-1496, 2019 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-31090309
8.
Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors.
Int J Cancer
; 143(2): 355-367, 2018 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29451304
9.
Epigenetic loss of heparan sulfate 3-O-sulfation sensitizes ovarian carcinoma to oncogenic signals and predicts prognosis.
Int J Cancer
; 143(8): 1943-1953, 2018 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29732534
10.
GATA3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells.
Int J Cancer
; 143(12): 3106-3119, 2018 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30006927
11.
Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients.
Hum Mol Genet
; 23(7): 1894-906, 2014 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24256813
12.
Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinoma.
J Obstet Gynaecol Res
; 42(9): 1159-67, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27226215
13.
Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm.
BMC Cancer
; 15: 418, 2015 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25985991
14.
Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells.
Int J Cancer
; 134(3): 542-51, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23904094
15.
Methylomics analysis identifies epigenetically silenced genes and implies an activation of ß-catenin signaling in cervical cancer.
Int J Cancer
; 135(1): 117-27, 2014 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24310984
16.
DNA methylation as a biomarker for the detection of hidden carcinoma in endometrial atypical hyperplasia.
Gynecol Oncol
; 135(3): 552-9, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25449566
17.
High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma.
Int J Gynecol Cancer
; 24(2): 201-9, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24407576
18.
Genome-wide analysis of cervical secretions obtained during embryo transfer reveals the association between deoxyribonucleic acid methylation and pregnancy outcomes.
F S Sci
; 3(1): 74-83, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35559997
19.
Endometrial Cancer Detection Using a Cervical DNA Methylation Assay (MPap) in Women with Abnormal Uterine Bleeding: A Multicenter Hospital-Based Validation Study.
Cancers (Basel)
; 14(17)2022 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077877
20.
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report.
J Ovarian Res
; 13(1): 143, 2020 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33292376